Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
Scientific Lecture | Kevin Harrington | FRONTAL
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
ESMO Immuno-Oncology Virtual Congress 2020 - YouTube
Randomised trial of pembrolizumab versus standard treatment in patients with recurrent or metastatic head and neck cancer - ecancer
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Potential of immunotherapy in head and neck cancer | VJOncology
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
T-VEC: what's next for oncolytic virotherapy and immuno-oncology? - Oncology Central
Professor Kevin Harrington, I [IMAGE] | EurekAlert! Science News Releases
Lapatinib not found to be beneficial in head and neck cancer with high risk of recurrence - ecancer
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Prof. Kevin Harrington | HSTalks
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
ESMO Immuno-Oncology Congress 2022 What you can expect - YouTube
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
Kevin Harrington | Speaker Agency, Speaking Fee, Videos | SPEAKING.com Keynote Speakers Bureau
Kevin Harrington | Videos & Research | VJOncology
Professor Kevin Harrington - The Institute of Cancer Research, London
Using Viruses to Treat Cancer | Prof Kevin Harrington | #SCIPEL 2015 | SCI - YouTube
Kevin Harrington - Reader in Biological Cancer Therapies - Institute of Cancer Research | LinkedIn
Scientific Advisory Board – PsiVac
SAB and I-O AB - T3 Pharma
